Invest in MJ Blog

Naturally Splendid Enters into Definitive Securities Purchase Agreement to Acquire 51% interest in POS BPC Manufacturing Corp. 

Vancouver, British Columbia - June 15, 2015 - Naturally Splendid Enterprises Ltd. ( “Naturally Splendid” or “NSE”) (FRANKFURT:50N) (TSX VENTURE:NSP) (OTC:NSPDF) is pleased to announce it has entered into a definitive securities purchase agreement (the “Purchase Agreement”) with POS Management Corp. (“POS Management” or “POS Bio-Sciences”), a wholly owned subsidiary of POS Holdings Corp. (“POS”), whereby POS Management will sell 51 Class A shares of POS BPC Manufacturing Corp. (“BPC”) to Naturally Splendid and, in consideration of which, Naturally Splendid has agreed to pay CAD $1,750,000 (the “Cash Payment”) to POS Management and will issue 367,647 common shares of Naturally Splendid (the “Consideration Shares”) at a deemed price of $0.68 per share to POS Management. POS Management also agreed that the Consideration Shares will be subject to a trading restriction for a period of 12 months from the date of issue.

World's Most Visible Cannabis TV Expert Makes Live Appearance at Canada Cannabis Conference Media Tour in Toronto on June 22, 2015

Beverly Hills, CA (PRWEB) June 14, 2015

Cheryl Shuman is pleased to announced that she has formed a joint venture alliance with both Jacob Securities and the Canada Cannabis Conference. In this international venture, Jacob Securities and Cheryl Shuman have teamed up to recruit the participation of the biggest names in the investment world, celebrity culture and in the legalized international marijuana market.

Cheryl Shuman will be hosting and presenting at the Canada Cannabis Conference, created by Jacob Securities Inc., on June 22, 2015

May 29, 2015 - Medbox, Inc. (OTCQB: MDBX), a leading provider of specialized consulting and technology solutions to the legal marijuana industry, today announced that its wholly owned subsidiary, Vaporfection, has signed an exclusive North American distribution agreement for its “miVape” vaporizer with VaporNation, the largest wholesaler and online retailer of vaporizers.

The miVape vaporizer, which is expected to be available for purchase in June, is a self-contained, USB-rechargeable unit that uses medical grade, food-safe and heat resistant materials to deliver the healthiest experience possible.

“VaporNation is a symbiotic fit for Vaporfection as we introduce our portable, true convection miVape vaporizer to the market. I believe it is truly a game changer in terms of its high-quality construction, superior performance and strict adherence to safety standards,” said Dan Wynick, President of Vaporfection. “Aligning with VaporNation provides access to a robust distribution network as well as amazing marketing opportunities that will help us meet the demand for a high-caliber, portable vaporizer at an affordable price.”

LAS VEGAS, May 27, 2015 /PRNewswire/ -- DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (OTCQB: DIGPD) opened the doors of its Las Vegas marijuana analytical testing laboratory for business today. Equipped with state of the art analytical instrumentation and operated under the direction of Cindy Orser, PhD, DigiPath Lab's flagship facility offers cannabis growers and marijuana-based product-makers fast and reliable results.

"This is a great day for the patients of Nevada who will benefit from medical marijuana," said DigiPath Labs president Todd Denkin. "Our analysis not only helps product producers and dispensaries screen out products with dangerous levels of contaminants, we also quantify the medicinal compounds present in samples, so patients and caregivers can choose products that have been shown to relieve their specific symptoms."

Surprisingly, compulsory cannabis testing is relatively new. The State of Colorado only began requiring product testing a year ago after a series of overdoses on edibles made the news. Washington State did not begin requiring testing for potency, contaminants, moisture and microbiology testing until 2013 when recreational cannabis became legal, even though the medicinal use of marijuana became legal in 1998.

BOCA RATON, FL--(Marketwired - May 29, 2015) - Earth Science Tech, Inc. (OTCQB: ETST) ("ETST" or "the Company"), a unique biotechnology company focused on nutraceuticals, bioceuticals and dietary supplements, announces positive progress on its High Grade CBD (Cannabidiol) Rich Hemp Oil in vitro studies on various human primary cells with DV Biologics, a leading biological company. In order to assure the public that ETST provides the best High Grade CBD (Cannabidiol) Rich Hemp Oil, we continue to focus on providing the public with sound scientific research and keeping the public informed on the progression of studies being done on our Hemp CBD products. DV Biologics, which is independently testing our ETST High Grade Hemp CBD Oil in vitro on various human primary cells, has informed us of the progression of studies being done. The goals of these studies are to test if ETST High Grade CBD Rich Hemp Oil serves as a neuroprotectant which may help with neurodegenerative disorders.

"Testing compounds in vitro on human cells is difficult. We recently tested various concentrations of ETST High Grade CBD Hemp Oil on various cells to see which concentrations are toxic to cells and noted that the cells grow similarly in concentrations from 1-10 micromolar. This is exciting news as it shows that this product, ETST High Grade CBD Hemp Oil, may be used in varying concentrations without toxicity to different cell types. We are now ready to test whether ETST High Grade CBD Hemp Oil can stop or deter free radical formation that occurs in vitro with brain cells. In order to do so, we will use varying concentrations of ETST Hemp CBD Oil and induce oxidative stress on brain cells. We will then test the cells to see if the ETST Hemp CBD Oil reduces oxidative stress and free radical formation compared to a control cell type that has no ETST High Grade CBD Hemp Oil. We look forward to reporting the full study in the near future," stated Dr. Rafael Gonzalez, Vice President of Research & Development of DV Biologics.